New York State Common Retirement Fund’s iShares Biotechnology ETF IBB Stock Holding History

New York State Common Retirement Fund’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-8,593	Closed	-$1.13M	–	3220
2022 Q4	$1.13M	Sell	8,593 -7,707	-47%	-$996K	﹤0.01%	1904
2022 Q3	$1.91M	Buy	16,300 +4,913	+43%	+$610K	﹤0.01%	1629
2022 Q2	$1.34M	Buy	11,387 +2,061	+22%	+$245K	﹤0.01%	1860
2022 Q1	$1.22M	Hold	9,326	–	–	﹤0.01%	2005
2021 Q4	$1.42M	Hold	9,326	–	–	﹤0.01%	1950
2021 Q3	$1.51M	Sell	9,326 -14,610	-61%	-$2.46M	﹤0.01%	1917
2021 Q2	$3.92M	Buy	+23,936	New	+$3.69M	﹤0.01%	1460

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

New York State Common Retirement Fund's IBB Position: Q1 2023 in Review

New York State Common Retirement Fund sold out of iShares Biotechnology ETF (IBB) in Q1 2023, closing a stake of 8,593 shares — an estimated $1.13M sold.

New York State Common Retirement Fund first reported a position in IBB in Q2 2021 and held it in 7 quarters. The position peaked at $3.92M in Q2 2021. 866 funds tracked by Wall St. Rank hold IBB as of Q1 2023.

New York State Common Retirement Fund reported no remaining iShares Biotechnology ETF position as of Q1 2023 after selling out during the quarter.
New York State Common Retirement Fund sold 8,593 iShares Biotechnology ETF shares in Q1 2023, an estimated $1.13M.
New York State Common Retirement Fund first reported a position in iShares Biotechnology ETF in Q2 2021 and held it in 7 quarters.
New York State Common Retirement Fund's iShares Biotechnology ETF position peaked at $3.92M in Q2 2021.
866 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2023.

Based on New York State Common Retirement Fund's 13F filing for Q1 2023, filed 2 May 2023.